Physician profile
Erin E Large
NPI 1114194966
$15,687.69
in general payments reported to CMS, 2019-2025
30 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,455 · 2020: $207 · 2021: $631 · 2022: $4,378 · 2023: $4,698 · 2024: $2,965 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,500 · Food and Beverage: $1,901 · Travel and Lodging: $601 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,500.00 |
| Food and Beverage | $1,901.15 |
| Travel and Lodging | $600.72 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10,106.42 | 2022-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $2,125.14 | 2019 | |
| Intuitive Surgical, INC. | $1,118.34 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $590.72 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $335.35 | 2021-2025 | |
| Astellas Pharma US INC | $183.11 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $178.98 | 2022-2025 | Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System |
| Exeltis, USA INC. | $153.45 | 2021-2025 | Slynd |
| Pacira Pharmaceuticals Incorporated | $98.26 | 2023 | Exparel |
| Covidien Lp | $96.27 | 2019 | |
| Pfizer INC. | $85.98 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.40 | 2020-2024 | |
| Baxter Healthcare | $83.02 | 2024 | Perclot |
| Millicent US INC | $61.71 | 2025 | Intrarosa, Femlyv |
| Minerva Surgical, INC | $49.14 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $41.36 | 2024-2025 | Spravato |
| Myovant Sciences INC. | $36.70 | 2021-2022 | |
| Amgen INC. | $28.67 | 2022-2023 | Evenity |
| Therapeuticsmd, INC. | $26.02 | 2019 | |
| Biogen, INC. | $25.47 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $24.77 | 2019-2020 | |
| Allergan, INC. | $23.59 | 2019-2020 | |
| Medtronic, INC. | $22.75 | 2024 | Ligasure |
| Applied Medical Resources Corporation | $20.72 | 2022 | |
| Meditrina | $18.33 | 2023 | |
| Avanos Medical | $17.84 | 2019 | |
| Roche Diagnostics Corporation | $14.58 | 2019 | |
| Sumitomo Pharma America, INC. | $13.71 | 2025 | Myfembree |
| Agile Therapeutics, INC. | $11.73 | 2022 | |
| Evofem Biosciences, INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Large listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.